Healthcare provider profile · identity verified

Tara M Scott, M.D.

Family Practice · LONG BEACH, CA · NPI 1245557545

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	259	82
Levothyroxine Sodium	Levothyroxine Sodium	246	67
Amlodipine Besylate	Amlodipine Besylate	203	65
Alendronate Sodium	Alendronate Sodium	149	39
Losartan Potassium	Losartan Potassium	142	44
Albuterol Sulfate Hfa	Albuterol Sulfate	123	44
Metoprolol Succinate	Metoprolol Succinate	119	35
Metformin Hcl	Metformin Hcl	102	33
Lisinopril	Lisinopril	94	28
Simvastatin	Simvastatin	86	24
Omeprazole	Omeprazole	78	26
Gabapentin	Gabapentin	75	24
Pantoprazole Sodium	Pantoprazole Sodium	70	18
Alprazolam	Alprazolam	69	25
Fluticasone Propionate	Fluticasone Propionate	67	20
Hydrochlorothiazide	Hydrochlorothiazide	65	18
Zolpidem Tartrate	Zolpidem Tartrate	64	23
Prednisone	Prednisone	56	43
Escitalopram Oxalate	Escitalopram Oxalate	55	18
Famotidine	Famotidine	55	17
Tramadol Hcl	Tramadol Hcl	52	17
Ondansetron Odt	Ondansetron	50	16
Benazepril Hcl	Benazepril Hcl	49	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	18
Meloxicam	Meloxicam	49	12
Trazodone Hcl	Trazodone Hcl	49	22
Lorazepam	Lorazepam	48	15
Montelukast Sodium	Montelukast Sodium	47	11
Ozempic	Semaglutide	46	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	45	38
Furosemide	Furosemide	44	15
Potassium Chloride	Potassium Chloride	43	14
Sertraline Hcl	Sertraline Hcl	40	suppressed
Atenolol	Atenolol	39	11
Rosuvastatin Calcium	Rosuvastatin Calcium	39	16
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	13
Bupropion Xl	Bupropion Hcl	36	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	16
Pravastatin Sodium	Pravastatin Sodium	36	11
Synthroid	Levothyroxine Sodium	35	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	34	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Azithromycin	Azithromycin	31	21
Donepezil Hcl	Donepezil Hcl	31	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Estradiol	Estradiol	28	suppressed
Acyclovir	Acyclovir	27	13
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Ibuprofen	Ibuprofen	26	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	19
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	24	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Eliquis	Apixaban	21	suppressed
Fluconazole	Fluconazole	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	18
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Glipizide	Glipizide	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	16
Farxiga	Dapagliflozin Propanediol	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	16
Valacyclovir	Valacyclovir Hcl	17	11
Diazepam	Diazepam	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Baclofen	Baclofen	15	suppressed
Finasteride	Finasteride	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Allopurinol	Allopurinol	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Anastrozole	Anastrozole	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Prolia	Denosumab	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error